I think there is the OPPORTUNITY for this to be very good for EMS and Artimist.
If Steve can get some 1:1 time with some influential people, then it stands to be a big positive for our plans going forward.
If there arent many poster presentations and therefore Artimist will stand out like the proverbial, then it stands to be positive for EMS and the visibility of Artimist.
Bottom line is IMO this conference can do NO HARM to EMS and Artimist. It should boost the visibility of the product significantly.
Whether any of this is announcement worthy and hence brings on a SP rise is yet to be seen.
Either way, its been 5 weeks since the announcement of the conclusion of the field trials, so we are getting closer to the release of the results.
EMS Price at posting:
3.0¢ Sentiment: None Disclosure: Held